Abstract:Background: Ulcerative colitis (UC) is a type of chronic inflammatory bowel disease (IBD) closely associated with intestinal homeostasis dysregulation. At present, clinical treatment options for UC are highly limited. Interleukin-22 (IL-22) treatment is regarded as an effective therapeutic strategy for the treatment of UC. The abnormal expression of long noncoding RNAs (lncRNAs) has been detected in many inflammatory diseases, including UC. In this study, we aimed to investigate the function of IL-22 and the function of lncRNAs in the UC on dextran sulfate sodium (DSS)-induced colitis in mice. Methods: The mice were intraperitoneally injected with IL-22 or PBS and then DSS was used to induce colitis. The histopathological parameters of the mice were determined using histological and molecular detection approaches. Then, RNA-sequencing was performed to screen the differential lncRNAs expression profile compared with the control group, before and after IL-22 treatment of the mice. Quantitative real time PCR (qRT-PCR) and lentivirus identified lncRNA-Ulcerative Colitis LncRNA (lncRNA-UCL) as the molecular regulator of the colitis mice. RNA-pulldown was performed to validate the interaction between lncRNA-UCL and mmu-miR-568. Meanwhile, claudin-1 was predicted and confirmed as the target molecule of mmu-miR-568 using dual luciferase assay. Findings: IL-22 treatment could significantly improve the histopathological features and decrease pro-inflammatory cytokine production in DSS-induced colitis mice by enhancing the expressions of tight and adherent junction proteins, and promoting the proliferation and suppressing the apoptosis of intestinal epithelial cells. LncRNA-UCL expression was significantly downregulated in DSS-induced colitis mice, while IL-22 treatment effectively reversed this effect. In terms of mechanism, lncRNA-UCL regulates intestinal epithelial homeostasis by sequestering mmu-miR-568 and maintaining the expression of the tight junction protein, claudin-1. Interpretation: Our results implied that IL-22 can alleviate symptoms of DSS-induced colitis via enhancing lncRNA-UCL expression by maintaining the expression levels of tight junction and adherent junction proteins. Therefore, the lncRNA/miR-568/claudin-1 axis plays a pivotal role in regulating intestinal epithelial cell homeostasis under the effect of IL-22.Funding: This study was supported by the National Natural Science Foundation of China (No.81800489). We are grateful to the collaboration of all fellows at Department ofGastroenterology, Shenzhen People’s Hospital, Jinan University.Declaration of Interest: The authors have declared that no competing interest exists.Ethical Approval: All experiments performed on animals were approved by the Medical EthicsCommittee of Shenzhen People’s Hospital, Shenzhen, China.

LncRNA CDKN2B-AS1 relieved inflammation of ulcerative colitis via sponging miR-16 and miR-195

Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis

Long Non-coding RNA MEG3 Alleviated Ulcerative Colitis Through Upregulating miR-98-5p-Sponged IL-10

Integrated Analysis of Circrnas and Mrnas Expression Profile Revealed the Involvement of Hsa_circ_0007919 in the Pathogenesis of Ulcerative Colitis

MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice

Effects of miR-939 and miR-376A on ulcerative colitis using a decoy strategy to inhibit NF-κB and NFAT expression

P001 MicroRNA-155-5p contributes to the development of Ulcerative Colitis by regulating T lymphocyte proliferation and functions

miR-141-3p alleviates ulcerative colitis by targeting SUGT1 to inhibit colonic epithelial cell pyroptosis

Il-22 Ameliorates Dss-Induced Colitis Through the Upregulation of LncRNA-UCL to Accelerate Claudin-1 Expression via Sequestering miR-568 in Mice

Down-regulation of miR-215 attenuates lipopolysaccharide-induced inflammatory injury in CCD-18co cells by targeting GDF11 through the TLR4/NF-kB and JNK/p38 signaling pathways

miR-195 plays a role in steroid resistance of ulcerative colitis by targeting Smad7.

Investigation of key miRNAs and their target genes in inflammatory bowel diseases and colitis-associated colorectal cancers using miRNA proifling and bioinformatic tools

Clinical Significance of microRNA-146a in Patients with Ulcerative Colitis

P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis

LINC01315 silencing inhibits the aggressive phenotypes of colorectal carcinoma by sponging miR-205-3p

[Knock-down of long noncoding RNA H19 (lncRNA H19) promotes human colorectal cell autophagy and inhibits cell apoptosis induced by lipopolysaccharide]

miR-370-3p Alleviates Ulcerative Colitis-Related Colorectal Cancer in Mice Through Inhibiting the Inflammatory Response and Epithelial-Mesenchymal Transition

Bioinformatics analysis of oxidative stress genes in the pathogenesis of ulcerative colitis based on a competing endogenous RNA regulatory network

Recovery of CD226-TIGIT+FoxP3+ and CD226-TIGIT-FoxP3+ Regulatory T Cells Contributes to Clinical Remission from Active Stage in Ulcerative Colitis Patients

METTL14 regulates inflammation in ulcerative colitis via the lncRNA DHRS4-AS1/miR-206/A3AR axis